Tay-Sachs disease is a rare genetic disorder that affects the brain. It usually starts in babies. Symptoms include a high startle response to noise, muscle weakness, loss of motor skills, and eventually blindness and paralysis. It's caused by a missing enzyme needed to break down a fatty substance in nerve cells.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Tay-Sachs disease is a rare inherited disorder that progressively damages nerve cells in the brain and spinal cord. People with the condition lack enough of an enzyme called beta-hexosaminidase A (often shortened to HEX A). Without it, a fatty substance called GM2 ganglioside cannot be broken down, and it builds up inside nerve cells until they stop working and die. The most common form begins in infancy. Babies usually seem healthy for the first few months, then between about 3 and 6 months they grow weaker, react to sudden noises with an exaggerated startle, and stop gaining new skills. Over the following months they lose abilities they already had, such as rolling over or sitting, and later develop seizures, vision and hearing loss, and trouble swallowing. Rarer forms start later. A juvenile form appears later in childhood, after normal early development. A late-onset form appears in older teenagers or adults. These forms progress more slowly and vary widely, often causing leg weakness, clumsiness, slurred speech and, in some people, psychiatric symptoms.
Tay-Sachs disease is caused by changes (variants) in the HEXA gene, which carries the instructions for making the HEX A enzyme. Nothing a parent did during pregnancy causes it, and it cannot be caught from someone else. Variants that eliminate the enzyme almost entirely tend to cause the infantile form, while variants that leave some enzyme working tend to cause the juvenile or late-onset forms. The condition is autosomal recessive: a child is affected only when they inherit a nonworking copy of the gene from each parent. People who carry one copy are called carriers. They have no symptoms and usually don't know unless they are tested. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with Tay-Sachs disease, a 50% chance of a child who is a carrier, and a 25% chance of a child who neither has the disease nor carries it. Carrier variants are more common in people of Ashkenazi (Central and Eastern European) Jewish heritage and in certain French-Canadian, Cajun (Louisiana) and Old Order Amish communities in Pennsylvania, but the disease can occur in any family. Widespread carrier testing in Ashkenazi Jewish communities has made the infantile form much less common there.
In a baby, the first clue is usually a pattern of slowing development followed by loss of skills, often with an exaggerated startle. An eye doctor may see a cherry-red spot on the retina at the back of the eye, a sign that is characteristic of the infantile form. The diagnosis is confirmed with two kinds of tests. A blood test measures HEX A enzyme activity, which is very low in Tay-Sachs disease (absent or nearly absent in the infantile form) while a related enzyme, HEX B, is normal or high. Genetic testing then looks for variants in both copies of the HEXA gene. Genetic testing matters because some harmless variants interfere only with the laboratory version of the enzyme test, making it look abnormal in a person who is healthy (called pseudodeficiency). Carrier screening uses the same tools in people without symptoms. It is ideally done before pregnancy, because it gives a couple the widest range of choices. When both partners are carriers, genetic counseling can explain the options, which include testing a pregnancy (through chorionic villus sampling, which samples placental tissue early in pregnancy, or amniocentesis, which samples the fluid around the baby somewhat later) and preimplantation genetic testing, where embryos created through in vitro fertilization are tested before transfer.
There is currently no cure for Tay-Sachs disease, and no treatment has been shown to stop it. Care focuses on comfort, function and preventing complications, usually through a team that may include neurology, genetics, nutrition, pulmonary care, palliative care and rehabilitation therapists. For infants and young children, the main goals are adequate nutrition and fluids, protecting the airway, treating infections and controlling seizures. As swallowing becomes harder, feeding changes, careful positioning during meals and eventually a feeding tube can reduce the risk of food or liquid going into the lungs. Seizure medicines are adjusted to balance seizure control against excessive sleepiness. For the juvenile and late-onset forms, physical, occupational and speech therapy aim to keep people moving, communicating and living as independently as possible, supported by mobility aids and home adaptations. Psychiatric symptoms in juvenile or late-onset Tay-Sachs need a specialist's input: some antipsychotic medicines, including haloperidol, risperidone and chlorpromazine, have been linked to worsening of the disease. Researchers are studying treatments aimed at the underlying cause. Miglustat, an oral medicine that reduces how much of the fatty substance the body makes, has been tried in small studies with inconsistent results and is not an established treatment. A specialist center can say whether any clinical trial is currently open.
The infantile form progresses quickly. Most children become unable to move on their own, see or swallow during the second year of life, and need more and more hands-on care for feeding, positioning and seizures. Even with good care, children with infantile Tay-Sachs disease usually die in early childhood, most often between ages 2 and 3, although some live to 5 to 7 years. Many families find that palliative care, home nursing and respite support help them focus on their child's comfort and time together. The juvenile form unfolds over years, with gradual loss of walking, speech and thinking skills, along with stiffness, swallowing difficulty and seizures. Most people with this form die in their teens, often from lung complications related to swallowing, although some live longer. The late-onset form changes slowly, and many people live well into adulthood. Muscle weakness, balance problems and speech changes tend to increase over time, and some people have periods of depression, mood changes or psychosis. Regular follow-up with a neurologist and rehabilitation team helps adjust support, prevent falls and plan ahead. Because symptoms vary even within the same family, past experience in relatives is only a rough guide.
See a pediatrician soon if a baby stops gaining new skills, loses skills such as rolling or sitting, startles excessively to ordinary sounds, or seems less visually attentive. For older children or adults, unexplained clumsiness, worsening weakness, slurred speech or new psychiatric symptoms are reasons to ask about a neurological evaluation. Anyone with a family history of Tay-Sachs disease, or a partner known to be a carrier, can ask about carrier testing and genetic counseling, ideally before pregnancy. For someone already diagnosed, contact the care team promptly about coughing or choking with feeds, fevers or chest infections, seizures that are becoming more frequent or different, or new feeding difficulties. A seizure that lasts longer than the child's seizure plan allows, or trouble breathing after choking or during a chest infection, needs the emergency steps agreed with the care team right away, such as giving rescue medicine or calling 911 if that is the plan.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Tay-Sachs Disease is like, what's helped you, or ask the community a question.